Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Capital/Financing Update 2003

Apr 6, 2003

65022_rns_2003-04-06_02adcabd-b6ac-42d0-992e-f5c16d86f5b1.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

April 7th, 2003

The Manager Company Announcements Office Australian Stock Exchange Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

Dear Sir.

GTG Grants License to Associated Regional & University Pathologists ("ARUP"), Salt Lake City, Utah, USA.

Genetic Technologies Limited (GTG-ASX) is pleased to announce it has granted a license to its non-coding patents to Associated Regional & University Pathologists (ARUP), Inc, of Salt Lake City, Utah, in USA.

ARUP is a sophisticated laboratory system owned by University of Utah. It performs an extensive range of pathology and genetic tests, some for its own research and teaching purposes, but much of it also for commercial service testing. This license is the first one granted by GTG to a service provider – that is, to a laboratory actually performing a wide range of genetic tests, some of which require access to GTG's inventions and patents.

The license takes effect from March 31st 2003, and ARUP now pays GTG an up-front fee of US\$75,000 (approx A\$125,000).

Negotiations with other service testing laboratories are also in progress, and further details will be provided as appropriate.

Yours faithfully,

Dr Mervyn Jacobson Executive Chairman